Investor Relations

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Latest Financial Results

Q2 2018

Quarter Ended Jun 30, 2018

Stock Information

Company Overview

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Corporate Factsheet

Corporate Factsheet

Download Corporate Factsheet

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2
Canada
T: 204.477.7592
ir@kanebiotech.com

Investor Relations

Edison Advisors
Tirth Patel
Vice President, Investor Relations
295 Madison Avenue, 18th Floor
New York, NY 10017
T: 646-653-7035
M: 386-295-2215
tpatel@edisongroup.com

Transfer Agent

Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1